Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/52931
DC FieldValueLanguage
dc.contributor.authorFernandez, A
dc.contributor.authorHortal, L
dc.contributor.authorBalda, I
dc.contributor.authorVega, N
dc.contributor.authorRodriguez, Jc
dc.contributor.authorPlaza, C
dc.contributor.authorPalop, L
dc.contributor.otherRodriguez-Perez, J.C.
dc.date.accessioned2019-02-04T14:23:39Z-
dc.date.available2019-02-04T14:23:39Z-
dc.date.issued1990
dc.identifier.issn0085-2538
dc.identifier.urihttp://hdl.handle.net/10553/52931-
dc.publisher0085-2538
dc.relation.ispartofKidney International
dc.sourceKidney International[ISSN 0085-2538],v. 37 (6), p. 1599-1599
dc.titleInitial Hematologic Evaluation Of The Treatment With Recombinant-Human-Erythropoietin (Rhuepo)
dc.typeinfo:eu-repo/semantics/article
dc.typeArticle
dc.identifier.isiA1990DF75600093
dcterms.isPartOfKidney International
dcterms.sourceKidney International[ISSN 0085-2538],v. 37 (6), p. 1599-1599
dc.description.lastpage1599
dc.identifier.issue6
dc.description.firstpage1599
dc.relation.volume37
dc.type2Artículo
dc.identifier.wosWOS:A1990DF75600093
dc.contributor.daisngid7847185
dc.contributor.daisngid702234
dc.contributor.daisngid28185065
dc.contributor.daisngid818914
dc.contributor.daisngid245684
dc.contributor.daisngid315895
dc.contributor.daisngid751953
dc.identifier.investigatorRIDC-1247-2010
dc.identifier.ulpgces
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Patología y Tecnología médica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.orcid0000-0003-0023-1063-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameRodríguez Pérez,José Carlos-
Appears in Collections:Artículos
Show simple item record

Google ScholarTM

Check


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.